Abstract:Klebsiella pneumoniae is a human pathogen, capable of forming biofilms on abiotic and biotic surfaces. The limitations of the therapeutic options against Klebsiella pneumoniae is actually due to its innate capabilities to form biofilm and harboring determinants of multidrug resistance. We utilized a newer approach for classification of biofilm producing Klebsiella pneumoniae isolates and subsequently we evaluated the chemistry of its slime, more accurately its biofilm. We extracted and determined the amount of polysaccharides and proteins from representative bacterial biofilms. The spatial distribution of sugars and proteins were then investigated in the biofilm matrix using confocal laser scanning microscopy (CLSM). Thereafter, the extracted matrix components were subjected to sophisticated analysis incorporating Fourier transform infrared (FTIR) spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, one-dimensional gel-based electrophoresis (SDS-PAGE), high performance liquid chromatography (HPLC), and MALDI MS/MS analysis. Besides, the quantification of its total proteins, total sugars, uronates, total acetyl content was also done. Results suggest sugars are not the only/major constituent of its biofilms. The proteins were harvested and subjected to SDS-PAGE which revealed various common and unique protein bands. The common band was excised and analyzed by HPLC. MALDI MS/MS results of this common protein band indicated the presence of different proteins within the biofilm. The 55 different proteins were identified including both cytosolic and membrane proteins. About 22 proteins were related to protein synthesis and processing while 15 proteins were identified related to virulence. Similarly, proteins related to energy and metabolism were 8 and those related to capsule and cell wall synthesis were 4. These results will improve our understanding of Klebsiella biofilm composition and will further help us design better strategies for controlling its biofilm such as techniques focused on weakening/targeting certain portions of the slime which is the most common building block of the biofilm matrix.

Promising strategies for future treatment of Klebsiella pneumoniae biofilms.

Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis

Relationship between biofilm formation and antibiotic resistance of Klebsiella pneumoniae and updates on antibiofilm therapeutic strategies

Treatment of Pseudomonas aeruginosa infectious biofilms: Challenges and strategies

Strategies for combating antibiotic resistance in bacterial biofilms

Emerging peptide-based technology for biofilm control

Promising Therapeutic Strategies Against Microbial Biofilm Challenges

Pseudomonas aeruginosa Biofilm Formation and Its Control

Innovative Strategies Toward the Disassembly of the EPS Matrix in Bacterial Biofilms

Classification of Clinical Isolates of Klebsiella pneumoniae Based on Their in vitro Biofilm Forming Capabilities and Elucidation of the Biofilm Matrix Chemistry With Special Reference to the Protein Content

Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies

Escaping the ESKAPE pathogens: A review on antibiofilm potential of nanoparticles

Mechanisms and Control Strategies of Antibiotic Resistance in Pathological Biofilms

Understanding the intricacies of microbial biofilm formation and its endurance in chronic infections: a key to advancing biofilm-targeted therapeutic strategies

Current Strategies for Combating Biofilm-Forming Pathogens in Clinical Healthcare-Associated Infections

Combating biofilm-associated Klebsiella pneumoniae infections using a bovine microbial enzyme

The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae

Strategy to combat biofilms: a focus on biofilm dispersal enzymes

Insights into the preventive actions of natural compounds against Klebsiella pneumoniae infections and drug resistance

Virulence Characteristics and Emerging Therapies for Biofilm-Forming Acinetobacter baumannii: A Review

Novel Strategies for the Prevention and Treatment of Biofilm Related Infections